Description:Mouse monoclonal antibody to human luteinizing hormone (LH)
Purification:Protein G affinity purified
Product Type:Primary antibody- capture antibody in matched antibody pair
Target Protein:Human LH αsubunit
Immunogen:Human LH αsubunit
Fusion Myeloma:Not known
Specificity:Human LH αsubunit
Species Reacitvity: Human, others not tested
Host / Isotype: Mouse, IgG1 Kappa
Formulation:Lyophilized from a solution in 0.01M PBS, pH 7.2
Reconstitution:Double distillated water is recommended to adjust the final concentration to 1.00 mg/mL.
Storage: Store at -20oC
Research Area:Hormone, ovulation
Background:
In the female menstrual cycle, during a 24-48 hour period, luteinizing hormone (LH) is rapidly released from gonadotropic cells in pituitary gland as a result of positive feedback regulation by the elevated estrogen during follicle maturation. The LH surge triggers the release of mature egg from ovarian follicle and the development of remaining follicle into corpus luteum. Progesterone secreted by corpus luteum is needed for preparing the endometrium for egg implantation. LH is critical for ovulation in women. In men, LH stimulates testis to produce testosterone.
LH has an αsubunit that is identical to the one in other glycoprotein hormones such as TSH, FSH and HCG. LH level is used for predicating ovulation in women to increase the chance of insemination.
Application:
ELISA:In combination with HRP conjugated anti-LH b mAb LH-2 (MO-M40048T), the antibody can be used as capture antibody to detect LH in sandwich ELISA application.
References:
If research is published using this product, please inform Anogen in order to cite the reference on this datasheet. Anogen will provide one unit of product in the same category as gratitude.
Product Specificity | mAb anti-Human LH, LH-1, Capture |
---|---|
Application | EIA |
Size | 0.5 mg |
Anogen-Yes Biotech Laboratories Ltd.是一家位于加拿大密西沙加的生物技术公司。成立于1989年,我们30年来一直是高质量抗体基产品的骄傲供应商。我们提供300多种单克隆和多克隆抗体,以及60多种类型的ELISA试剂盒,用于研究,诊断和治疗应用。
作为一家专注于研究的公司,我们还开发了许多专有的诊断和治疗产品。我们的产品Abcream是一种有效的抗牛皮癣局部抗IL-8(CXCL8)单克隆抗体,已于2001年获得中国国家食品药品监督管理局(SFDA)的批准,并获得多项国际专利。我们的用于诊断目的的新生儿TSH ELISA试剂盒也已获得加拿大卫生部的许可。我们还启动了针对炎症,阿尔茨海默氏病和癌症的研究和开发产品。